🟢 Nutex Health is trading 5% up today with a Strong Buy rating and $290.43 target

Nutex Health is trading at $214.99, up +5.08%, after Seeking Alpha reported a Strong Buy rating and a $290.43 price target, implying 39.1% upside. - The bullish view cites stronger financial expectations, including projected FY2026 EPS of $27.79, effective No Surprises Act arbitration use, and cost control. - Nutex Health received approval for a Nasdaq Texas dual listing, adding visibility around the company.